Theravance Biopharma Share Holder Equity 2012-2025 | TBPH

Theravance Biopharma share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Theravance Biopharma Annual Share Holder Equity
(Millions of US $)
2024 $176
2023 $213
2022 $442
2021 $-339
2020 $-304
2019 $-224
2018 $-52
2017 $115
2016 $350
2015 $243
2014 $290
2013 $-17
2012 $-7
2011 $0
Theravance Biopharma Quarterly Share Holder Equity
(Millions of US $)
2025-03-31 $166
2024-12-31 $176
2024-09-30 $186
2024-06-30 $194
2024-03-31 $205
2023-12-31 $213
2023-09-30 $246
2023-06-30 $280
2023-03-31 $371
2022-12-31 $442
2022-09-30 $481
2022-06-30 $-350
2022-03-31 $-351
2021-12-31 $-339
2021-09-30 $-324
2021-06-30 $-300
2021-03-31 $-373
2020-12-31 $-304
2020-09-30 $-262
2020-06-30 $-202
2020-03-31 $-158
2019-12-31 $-224
2019-09-30 $-183
2019-06-30 $-137
2019-03-31 $-113
2018-12-31 $-52
2018-09-30 $-13
2018-06-30 $34
2018-03-31 $63
2017-12-31 $115
2017-09-30 $184
2017-06-30 $241
2017-03-31 $294
2016-12-31 $350
2016-09-30 $298
2016-06-30 $322
2016-03-31 $239
2015-12-31 $243
2015-09-30 $223
2015-06-30 $258
2015-03-31 $289
2014-12-31 $290
2014-09-30 $340
2014-06-30 $385
2014-03-31 $-18
2013-12-31 $-17
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $-7
2011-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.531B $0.064B
Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.?
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.377B 32.78
Zoetis (ZTS) United States $74.051B 27.63
Takeda Pharmaceutical (TAK) Japan $48.270B 9.60
Daiichi Sankyo, - (DSNKY) Japan $47.264B 24.22
BeOne Medicines - (ONC) Cayman Islands $28.732B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.880B 0.00
Merck (MKKGY) Germany $17.149B 12.56
Shionogi (SGIOY) Japan $14.717B 14.74
Summit Therapeutics (SMMT) United States $14.541B 0.00
United Therapeutics (UTHR) United States $12.471B 11.03
Neurocrine Biosciences (NBIX) United States $12.289B 42.09
Orion OYJ (ORINY) Finland $10.289B 27.82
IPSEN (IPSEY) France $9.940B 0.00
Corcept Therapeutics (CORT) United States $7.555B 61.41
Stevanato Group S.p.A (STVN) Italy $7.501B 45.87
Madrigal Pharmaceuticals (MDGL) United States $6.535B 0.00
Grifols, S.A (GRFS) Spain $6.154B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.760B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Catalyst Pharmaceuticals (CPRX) United States $3.099B 10.86
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.438B 13.19
NewAmsterdam Pharma (NAMS) Netherlands $2.302B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.220B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.195B 0.00
Indivior (INDV) United States $1.883B 7.99
Centessa Pharmaceuticals (CNTA) United Kingdom $1.668B 0.00
Dyne Therapeutics (DYN) United States $1.656B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.408B 0.00
Ocular Therapeutix (OCUL) United States $1.405B 0.00
Guardian Pharmacy Services (GRDN) United States $1.276B 0.00
Harrow (HROW) United States $1.160B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Enliven Therapeutics (ELVN) United States $0.962B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.957B 0.00
Collegium Pharmaceutical (COLL) United States $0.954B 5.15
Akebia Therapeutics (AKBA) United States $0.938B 0.00
Ardelyx (ARDX) United States $0.885B 0.00
Cronos Group (CRON) Canada $0.756B 0.00
Elite Pharmaceuticals (ELTP) United States $0.726B 0.00
Xeris Biopharma Holdings (XERS) United States $0.685B 0.00
Xencor (XNCR) United States $0.678B 0.00
KalVista Pharmaceuticals (KALV) United States $0.669B 0.00
AleAnna (ANNA) United States $0.587B 0.00
Relay Therapeutics (RLAY) United States $0.573B 0.00
Verve Therapeutics (VERV) United States $0.570B 0.00
Regulus Therapeutics (RGLS) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Bioventus (BVS) United States $0.551B 13.98
Altimmune (ALT) United States $0.530B 0.00
Zevra Therapeutics (ZVRA) United States $0.513B 0.00
Tourmaline Bio (TRML) United States $0.490B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Siga Technologies (SIGA) United States $0.453B 9.46
Organogenesis (ORGO) United States $0.412B 0.00
Savara (SVRA) United States $0.380B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.379B 10.24
Aquestive Therapeutics (AQST) United States $0.339B 0.00
Heron Therapeutics (HRTX) United States $0.314B 0.00
Liminatus Pharma (LIMN) United States $0.289B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
ProKidney (PROK) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.10
Esperion Therapeutics (ESPR) United States $0.240B 0.00
Nanobiotix S.A (NBTX) France $0.239B 0.00
MediWound (MDWD) Israel $0.223B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Larimar Therapeutics (LRMR) United States $0.198B 0.00
OmniAb (OABI) United States $0.198B 0.00
Aldeyra Therapeutics (ALDX) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.170B 0.00
Journey Medical (DERM) United States $0.161B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Lexeo Therapeutics (LXEO) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Lyell Immunopharma (LYEL) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Achieve Life Sciences (ACHV) Canada $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.119B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
VAXART, INC (VXRT) United States $0.115B 0.00
Fractyl Health (GUTS) United States $0.111B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Wellgistics Health (WGRX) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Inotiv (NOTV) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.087B 14.25
Cumberland Pharmaceuticals (CPIX) United States $0.085B 63.00
Nutriband (NTRB) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Jupiter Neurosciences (JUNS) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Prelude Therapeutics (PRLD) United States $0.062B 0.00
NRx Pharmaceuticals (NRXP) United States $0.060B 0.00
PMV Pharmaceuticals (PMVP) United States $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Avalo Therapeutics (AVTX) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
FibroGen (FGEN) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
Relmada Therapeutics (RLMD) United States $0.025B 0.00
Carisma Therapeutics (CARM) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.11
Ainos (AIMD) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00